Total Payments
$435,377
2024 Payments
$46,758
Companies
77
Transactions
1,709
Medicare Patients
14,079
Medicare Billing
$705,376
Payment Breakdown by Category
Other$326,146 (74.9%)
Food & Beverage$45,168 (10.4%)
Travel$34,515 (7.9%)
Consulting$27,223 (6.3%)
Research$2,027 (0.5%)
Education$298.61 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $295,823 | 144 | 67.9% |
| Food and Beverage | $45,168 | 1,338 | 10.4% |
| Travel and Lodging | $34,515 | 172 | 7.9% |
| Consulting Fee | $27,223 | 15 | 6.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $19,025 | 10 | 4.4% |
| Honoraria | $8,898 | 3 | 2.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,400 | 2 | 0.6% |
| Unspecified | $2,027 | 8 | 0.5% |
| Education | $298.61 | 17 | 0.1% |
Payments by Type
General
$433,350
1,701 transactions
Research
$2,027
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $77,538 | 146 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $64,608 | 180 | $0 (2024) |
| Shire North American Group Inc | $64,596 | 122 | $0 (2019) |
| Abbott Laboratories | $57,215 | 123 | $0 (2024) |
| Amgen Inc. | $56,056 | 173 | $0 (2024) |
| Merck Sharp & Dohme LLC | $29,002 | 68 | $0 (2024) |
| Intuity Medical Inc | $25,610 | 20 | $0 (2023) |
| Chiesi USA, Inc. | $14,399 | 25 | $0 (2024) |
| Corcept Therapeutics | $8,950 | 54 | $0 (2024) |
| Mannkind Corporation | $5,128 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,758 | 217 | Amgen Inc. ($18,158) |
| 2023 | $54,195 | 221 | Abbott Laboratories ($20,119) |
| 2022 | $64,761 | 175 | Amgen Inc. ($18,072) |
| 2021 | $12,173 | 106 | Abbott Laboratories ($5,301) |
| 2020 | $26,180 | 144 | Janssen Pharmaceuticals, Inc ($11,605) |
| 2019 | $68,346 | 250 | Janssen Pharmaceuticals, Inc ($28,702) |
| 2018 | $89,760 | 308 | Janssen Pharmaceuticals, Inc ($34,636) |
| 2017 | $73,203 | 288 | Shire North American Group Inc ($28,468) |
All Payment Transactions
1,709 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Bone Health | ||||||
| 12/19/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 11/25/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $98.08 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $2.75 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Durable Pump | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $275.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Bone Health | ||||||
| 11/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $137.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study 455 | Corcept Therapeutics | $2,027 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 3,559 | 7,069 | $722,018 | $198,024 |
| 2022 | 40 | 3,660 | 7,342 | $525,747 | $175,724 |
| 2021 | 42 | 3,470 | 7,032 | $580,728 | $182,584 |
| 2020 | 40 | 3,390 | 6,159 | $500,698 | $149,044 |
Total Patients
14,079
Total Services
27,602
Medicare Billing
$705,376
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 430 | $168,033 | $46,532 | 27.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 330 | $153,361 | $24,400 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 274 | $75,461 | $21,557 | 28.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 64 | $72,450 | $10,364 | 14.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 238 | 543 | $22,806 | $8,938 | 39.2% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 238 | 538 | $22,784 | $8,931 | 39.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 65 | 67 | $23,867 | $7,039 | 29.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 222 | 504 | $16,869 | $6,612 | 39.2% |
| 82985 | Glycated protein level | Office | 2023 | 175 | 397 | $16,634 | $6,519 | 39.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $21,868 | $6,271 | 28.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 33 | 33 | $20,528 | $5,804 | 28.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 154 | 196 | $14,504 | $5,686 | 39.2% |
| 83721 | Ldl cholesterol level | Office | 2023 | 222 | 508 | $13,388 | $5,227 | 39.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 237 | 502 | $13,253 | $5,196 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 245 | 579 | $5,657 | $4,817 | 85.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 238 | 544 | $12,267 | $4,809 | 39.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 228 | 476 | $9,244 | $3,622 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 44 | $6,708 | $3,165 | 47.2% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 216 | 489 | $7,956 | $3,120 | 39.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 34 | 34 | $4,009 | $1,586 | 39.6% |
| 80074 | Acute hepatitis panel | Office | 2023 | 20 | 21 | $2,500 | $980.28 | 39.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 19 | 22 | $2,270 | $889.90 | 39.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 20 | 22 | $1,419 | $556.38 | 39.2% |
| 86800 | Thyroglobulin (thyroid protein) antibody measurement | Office | 2023 | 29 | 35 | $1,392 | $545.65 | 39.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 36 | $1,357 | $532.08 | 39.2% |
About Dr. Isaac Sachmechi, MD
Dr. Isaac Sachmechi, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750340121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Isaac Sachmechi, MD has received a total of $435,377 in payments from pharmaceutical and medical device companies, with $46,758 received in 2024. These payments were reported across 1,709 transactions from 77 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($295,823).
As a Medicare-enrolled provider, Sachmechi has provided services to 14,079 Medicare beneficiaries, totaling 27,602 services with total Medicare billing of $705,376. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location New Hyde Park, NY
- Active Since 03/22/2006
- Last Updated 04/21/2015
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1750340121
Products in Payments
- INVOKANA (Drug) $76,683
- FARXIGA (Drug) $59,097
- EVENITY (Biological) $48,704
- NATPARA (Drug) $45,209
- FREESTYLE LIBRE 3 (Device) $27,782
- Pogo Automatic Blood Glucose Monitoring System (Device) $25,610
- JANUVIA (Drug) $17,900
- NATPARA (PARATHYROID HORMONE) (Drug) $14,911
- MYCAPSSA (Drug) $14,785
- FREESTYLE LIBRE (Device) $13,039
- FreeStyle Libre Pro (Device) $8,105
- FREESTYLE LIBRE 2 (Device) $7,453
- Korlym (Drug) $6,923
- Tirosint (Drug) $6,332
- Prolia (Biological) $5,710
- STEGLATRO (Drug) $5,519
- AFREZZA (Drug) $5,128
- BYDUREON (Drug) $4,586
- Roszet (Drug) $4,073
- CYCLOSET (Drug) $2,159
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in New Hyde Park
Dr. Rory Breidbart, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $158,723
Endocrinology, Diabetes & Metabolism $158,723
Kenneth Hershon, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $140,805
Endocrinology, Diabetes & Metabolism $140,805
Stuart Weinerman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $53,888
Endocrinology, Diabetes & Metabolism $53,888
Russell Dambra, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $4,596
Endocrinology, Diabetes & Metabolism $4,596
Angella Mashkabova, Pa, PA
Endocrinology, Diabetes & Metabolism — Payments: $3,804
Endocrinology, Diabetes & Metabolism $3,804
Ronda Bloom, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,630
Endocrinology, Diabetes & Metabolism $3,630